Neville-Webbe H - Search Results

1

Coleman R, Burkinshaw R, Winter M, Neville-Webbe H, Lester J, Woodward E, Brown J. Coleman R, et al. Among authors: neville webbe h. Expert Opin Drug Saf. 2011 Jan;10(1):133-45. doi: 10.1517/14740338.2011.540387. Epub 2010 Nov 29. Expert Opin Drug Saf. 2011. PMID: 21114419 Review.

2

Sequence- and schedule-dependent enhancement of zoledronic acid induced apoptosis by doxorubicin in breast and prostate cancer cells.

Neville-Webbe HL, Rostami-Hodjegan A, Evans CA, Coleman RE, Holen I. Neville-Webbe HL, et al. Int J Cancer. 2005 Jan 20;113(3):364-71. doi: 10.1002/ijc.20602. Int J Cancer. 2005. PMID: 15455384

3

Combined effects of zoledronic acid and doxorubicin on breast cancer cell invasion in vitro.

Woodward JK, Neville-Webbe HL, Coleman RE, Holen I. Woodward JK, et al. Anticancer Drugs. 2005 Sep;16(8):845-54. doi: 10.1097/01.cad.0000175582.01446.6f. Anticancer Drugs. 2005. PMID: 16096432

4

The role of bisphosphonates in breast and prostate cancers.

Brown JE, Neville-Webbe H, Coleman RE. Brown JE, et al. Endocr Relat Cancer. 2004 Jun;11(2):207-24. doi: 10.1677/erc.0.0110207. Endocr Relat Cancer. 2004. PMID: 15163299 Review.

5

Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction.

Neville-Webbe HL, Coleman RE, Holen I. Neville-Webbe HL, et al. Br J Cancer. 2010 Mar 16;102(6):1010-7. doi: 10.1038/sj.bjc.6605579. Epub 2010 Feb 16. Br J Cancer. 2010. PMID: 20160726 Free PMC article.

6

Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease.

Neville-Webbe HL, Coleman RE. Neville-Webbe HL, et al. Eur J Cancer. 2010 May;46(7):1211-22. doi: 10.1016/j.ejca.2010.02.041. Epub 2010 Mar 27. Eur J Cancer. 2010. PMID: 20347292 Review.

7

Potential anticancer properties of bisphosphonates.

Neville-Webbe HL, Gnant M, Coleman RE. Neville-Webbe HL, et al. Semin Oncol. 2010 Jun;37 Suppl 1:S53-65. doi: 10.1053/j.seminoncol.2010.06.008. Semin Oncol. 2010. PMID: 20682373 Review.

8

Mechanisms of the synergistic interaction between the bisphosphonate zoledronic acid and the chemotherapy agent paclitaxel in breast cancer cells in vitro.

Neville-Webbe HL, Evans CA, Coleman RE, Holen I. Neville-Webbe HL, et al. Tumour Biol. 2006;27(2):92-103. doi: 10.1159/000092489. Epub 2006 Mar 24. Tumour Biol. 2006. PMID: 16582586

9

The anti-tumour activity of bisphosphonates.

Neville-Webbe HL, Holen I, Coleman RE. Neville-Webbe HL, et al. Cancer Treat Rev. 2002 Dec;28(6):305-19. doi: 10.1016/s0305-7372(02)00095-6. Cancer Treat Rev. 2002. PMID: 12470981 Review.

10

Magnesium depletion in patients receiving cisplatin-based chemotherapy.

Hodgkinson E, Neville-Webbe HL, Coleman RE. Hodgkinson E, et al. Clin Oncol (R Coll Radiol). 2006 Nov;18(9):710-8. doi: 10.1016/j.clon.2006.06.011. Clin Oncol (R Coll Radiol). 2006. PMID: 17100159

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters